GlassScriptPhysician profile
Anay Thodge
NPI 1902338189
$3,090.34
in general payments reported to CMS, 2019-2025
7 companies · $441 in 2025
The $441 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $97.66 · 2023: $2,398 · 2024: $154 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,742 · Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,741.78 |
| Food and Beverage | $1,250.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,373.15 | 2023-2024 | Indigo System |
| Sirtex Medical INC | $273.85 | 2025 | Sir-Spheres Microspheres |
| Inari Medical, INC. | $248.16 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $146.24 | 2023-2025 | Osteocool Rf Ablation System |
| Boston Scientific Corporation | $19.79 | 2025 | Embold Fibered |
| Pfizer INC. | $15.91 | 2025 | |
| Siemens Medical Solutions USA, INC. | $13.24 | 2024 | Varian Cryocare Touch System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anay Thodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.